iRhythm posts Q1 sales beat, FDA warning letter remains on track

iRhythm (Nasdaq: IRTC) shares dipped slightly today on first-quarter results that topped the consensus sales forecast.

Related Keywords

Massdevice Medtech ,Quentin Blackford ,Marie Thibault ,Sam Eiber , ,San Francisco Based ,Zio Mobile Cardiac Telemetry ,